More than 2,680 births happened the province during the first semester of 2018, with an infant mortality rate of 2.6 per thousand live births, among the lowest in the country and much lower than the 4.8 registered in the same stage of the previous year.
Cuban researchers from the Genetic Engineering and Biotechnology Center (CIGB) of Havana are testing a therapeutic vaccine against solid tumors, one of the 'top priority' of the state group Biocubafarma that also lists among its products seven other 'high impact' medicines.
The Cuban company Combiomed runs three main lines of business to guarantee good cardiovascular health, the firm's commercial director, Leonor Gálvez, said here today.
More than 362 people from Las Tunas have benefited from Heberprot-P so far this year, a prescribed treatment for diabetic foot ulcer (DFU). This became known during the semiannual evaluation of the Comprehensive Care Program for patients with this condition in the territory and its pre-congress Scientific Day.